News | Magnetic Resonance Imaging (MRI)

HeartVista announced its artificial intelligence (AI)-driven, One-Click Autonomous MRI acquisition software for cardiac exams. Integrated with existing magnetic resonance imaging (MRI) scanners, the software uses AI to guide image acquisition.

Home November 25, 2018
Home
News | Endovascular Aortic Repair

New research in the December edition of the Journal of Vascular Surgery suggests significant increase in morbidities in obese patients after open surgery, but not after endovascular abdominal aortic aneurysm (AAA) repair.

Home November 21, 2018
Home
News | Thrombectomy Devices

November 21, 2018 — BTG plc announced the first Ekos CU 4.0 units have been shipped from BTG’s facility in Bothell, Wash ...

Home November 21, 2018
Home
News | Vascular Closure Devices

Vivasure Medical Ltd. recently announced the European launch of the PerQseal closure device for large-bore transcatheter procedures.

Home November 21, 2018
Home
Russel Pate, Ph.D., Univerity Of South Carolina, chair of the National Physical Activity Plan Alliance. #AHA18
Feature | AHA

November 7, 2018 — Here is a list of some of the key clinical trial presentations at the 2018 American Heart Association ...

Home November 20, 2018
Home
News

November 16, 2018 — A research team led by scientists and doctors in Leicester and the Netherlands has shown that a ...

Home November 19, 2018
Home
News | Cardiovascular Ultrasound

Medical artificial intelligence (AI) company Bay Labs and Northwestern Medicine announced that the first patient has been enrolled in a first-of-its-kind study. The study will evaluate the use of Bay Labs’ EchoGPS cardiac ultrasound guidance software to enable certified medical assistants (CMAs) as medical professionals with no prior scanning experience to capture high-quality echocardiograms. The study will also evaluate the use of its EchoMD measurement and interpretation software suite to detect certain types of heart disease among patients 65 years and older undergoing routine physical examinations in primary care settings.

Home November 19, 2018
Home
Videos | AHA

DAIC Editor Dave Fornell takes a tour of some of the most innovative new cardiovascular technologies on display on the ...

Home November 19, 2018
Home
News | Cardiovascular Clinical Studies

The U.S. Food and Drug Administration (FDA) is proposing to add an exception to informed consent requirements for certain FDA-regulated clinical investigations that present no more than minimal risk to human research participants.

Home November 19, 2018
Home
Sponsored Content | Videos | Cath Lab

Navin Kapur, M.D., discusses the results of the FDA STEMI Door-to-Unloading (DTU) safety and feasibility randomized ...

Home November 15, 2018
Home
News | Nuclear Imaging

GE Healthcare announced it is recalling its Millennium Nuclear Medicine Systems due to an incident in which the the top detector detached and fell onto the detector below it. No patient injuries have been reported, although there remains a risk of potential life-threatening bodily harm if the detector were to detach and fall during a patient exam. The U.S. Food and Drug Administration (FDA) has identified this as a Class I recall, the most serious type of recall.

Home November 15, 2018
Home
News | Pharmaceuticals

AstraZeneca announced positive full results from the DECLARE-TIMI 58 cardiovascular (CV) outcomes trial (CVOT) for Farxiga (dapagliflozin) as a late-breaking abstract at the American Heart Association (AHA) Scientific Sessions 2018, Nov. 10-12 in Chicago. Results were simultaneously published in the New England Journal of Medicine (NEJM).

Home November 15, 2018
Home
Videos | Heart Failure

James Januzzi, M.D., Hutter Family Professor at Harvard Medical School and a cardiologist at Mass General Hospital ...

Home November 15, 2018
Home
Videos | EP Lab

Wilber Su, M.D., chief of cardiac electrophysiology, Banner University Medical Center, Phoenix, and clinical associate ...

Home November 15, 2018
Home
News | Cardiac Diagnostics

The U.S. Department of Health and Human Services (HHS) released the second edition of the Physical Activity Guidelines for Americans at the American Heart Association’s (AHA) 2018 Scientific Sessions, Nov. 10-12 in Chicago. The second edition — announced at AHA by Adm. Brett P. Giroir, M.D., assistant secretary for health — provides evidence-based recommendations for youth ages three through 17 and adults to safely get the physical activity they need to stay healthy.

Home November 14, 2018
Home
Subscribe Now